Stock Earnings

Question 1

Quels sont les états financiers clés de Telix Pharmaceuticals Ltd ?

Accepted Answer

Selon le dernier état financier (Form-10K), Telix Pharmaceuticals Ltd a un total d'actifs de $983, un bénéfice net profit de $32

Question 2

Quels sont les ratios financiers clés pour TLPPF ?

Accepted Answer

Le ratio de liquidité de Telix Pharmaceuticals Ltd est 1.6, la marge nette est 6.31, les ventes par action sont de $1.46.

Question 3

Comment les revenus de Telix Pharmaceuticals Ltd sont-ils répartis par segment ou géographie ?

Accepted Answer

Telix Pharmaceuticals Ltd largest revenue segment is Precision Medicine, at a revenue of 771,106,000 in the most earnings release.For geography, United States is the primary market for Telix Pharmaceuticals Ltd, at a revenue of 762,308,000.

Question 4

Telix Pharmaceuticals Ltd est-elle rentable ?

Accepted Answer

yes, selon les derniers états financiers, Telix Pharmaceuticals Ltd a un bénéfice net profit de $32

Question 5

Telix Pharmaceuticals Ltd a-t-elle des passifs ?

Accepted Answer

yes, Telix Pharmaceuticals Ltd a un passif de 614

Question 6

Combien d'actions en circulation Telix Pharmaceuticals Ltd a-t-elle ?

Accepted Answer

Telix Pharmaceuticals Ltd a un total d'actions en circulation de 334.72

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	662	507	325	103	7	5
Revenue Growth (YoY)	27%	56%	216%	1,371%	40%	67%
Cost of Revenue	304	194	122	42	2	2
Gross Profit	357	313	203	61	5	3
Selling, General & Admin	168	128	86	56	46	24
Research & Development	153	126	83	52	34	23
Operating Expenses	329	262	192	120	81	38
Other Non Operating Income (Expenses)	-26	-19	-8	-4	-5	0
Pretax Income	9	36	2	-63	-80	-47
Income Tax Expense	-1	3	-1	3	0	-3
Net Income	10	32	3	-67	-80	-44
Net Income Growth	-74%	967%	-104%	-16%	82%	63%
Shares Outstanding (Diluted)	337.2	345.18	323.71	310.64	282.2	257.27
Shares Change (YoY)	3%	7%	4%	10%	10%	10%
EPS (Diluted)	0.02	0.09	0.01	-0.21	-0.28	-0.17
EPS Growth	-75%	802%	-105%	-24%	64%	46%
Free Cash Flow	-23	-3	8	-50	-60	1
Free Cash Flow Per Share	-0.06	0	0.02	-0.16	-0.21	0
Gross Margin	53.92%	61.73%	62.46%	59.22%	71.42%	60%
Operating Margin	4.07%	10.05%	3.38%	-56.31%	-1,085.71%	-700%
Profit Margin	1.51%	6.31%	0.92%	-65.04%	-1,142.85%	-880%
Free Cash Flow Margin	-3.47%	-0.59%	2.46%	-48.54%	-857.14%	20%
EBITDA	--	--	--	-53	-71	-31
EBITDA Margin	--	--	--	-51.45%	-1,014.28%	-620%
D&A For EBITDA	--	--	--	5	5	4
EBIT	27	51	11	-58	-76	-35
EBIT Margin	4.07%	10.05%	3.38%	-56.31%	-1,085.71%	-700%
Effective Tax Rate	-11.11%	8.33%	-50%	-4.76%	0%	6.38%

Telix Pharmaceuticals Ltd (TLPPF) Price

TLPPF Stock Price Chart

TLPPF Income

Follow-Up Questions